CT HB05430

Prescribing practitioners must establish a treatment agreement or care plan with patients prescribed opioids for pain lasting longer than twelve weeks, including treatment goals, opioid risks, urine drug screens, and nonopioid treatment alternatives (effective July 1, 2022).

Expands the definition of "drug paraphernalia" to clarify covered equipment and adds an exemption for licensed manufacturers and individuals testing substances to prevent accidental overdose (effective July 1, 2022).

Requires practitioners prescribing controlled substances to register with the electronic prescription drug monitoring program and notify the Department of Consumer Protection when transporting controlled substances to treat patients at locations other than their registered address (effective July 1, 2022).

Permits multicare institutions to provide behavioral health and substance use disorder treatment services, including methadone delivery and mobile narcotic treatment programs, at multiple locations and satellite units (effective July 1, 2022).

Establishes a peer navigator pilot program in up to five urban, suburban, and rural communities to serve persons with opioid use disorder by January 1, 2023, with a report due by January 1, 2024 (effective upon passage).